Verbal Beginnings to Open New Early Intervention Comprehensive Autism Services Center in Annapolis, MD
09 févr. 2024 09h33 HE | Verbal Beginnings
Verbal Beginnings, a leading provider of comprehensive autism services, is thrilled to announce the opening of a new location in Annapolis, Maryland.
Webinar Presenter
Developing Biological Markers to Improve Clinical Care in Autism - A Free Webinar from the Brain & Behavior Research Foundation
06 févr. 2024 10h15 HE | Brain & Behavior Research Foundation
New York, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Developing Biological Markers to Improve Clinical Care in Autism” on...
SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
29 janv. 2024 07h18 HE | SciSparc Ltd
The clinical trial for SCI-210 will be conducted in Israel, after which the company aims to move forward with the commercialization process of SCI-210 first in the Israeli market TEL AVIV,...
Global Neurological Biomarkers Market
Global Neurological Biomarkers Market Analysis Report 2024-2030 - CAGR of 12.8% - Increased Funding For R&D in Biomarkers to Boost Development of New Drugs
24 janv. 2024 05h40 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Neurological Biomarkers Market Size, Share & Trends Analysis Report by Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism),...
Hopebridge Introduce
Hopebridge Introduces Intuitive Patient Portal for Easier Access to Personalized Pediatric Care and Communications
17 janv. 2024 08h00 HE | Hopebridge
INDIANAPOLIS, IN, Jan. 17, 2024 (GLOBE NEWSWIRE) -- To continue its vision of expanding access to quality, pediatric therapy and diagnostic services, Hopebridge recently launched a new patient...
AXIAL Logo 2021MAR05.png
Axial Therapeutics to Present at Upcoming Conferences
05 janv. 2024 08h05 HE | Axial Therapeutics
WOBURN, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Axial Therapeutics, a clinical-stage biotechnology company dedicated to the development of gut-targeted, small molecule therapeutics for neurological...
Xolv Creates a New Venture to Embark on New Era of Innovation in Behavioral Health
03 janv. 2024 16h53 HE | Xolv
WALNUT CREEK, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Xolv, formerly Catalight’s IT and technology innovation group, proudly announces its transition to a new corporation today as part of a...
NeuroQure Logo.png
NeuroQure Acquires Patents to Detect Autism in Newborns with a Skin Sample
13 déc. 2023 09h30 HE | NeuroQure
IRVINE, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- NeuroQure, a pioneering biotech startup specializing in gene therapy for neurocognitive disorders, has reached a pivotal milestone in the...
New Hope for Children: SciSparc's patented CBD- Enhanced Solution for Autism Spectrum Disorder
24 nov. 2023 08h55 HE | SciSparc Ltd
TEL AVIV, Israel, Nov. 24, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...
Lindsey Sneed
Study: Autistic Children May Need Fewer Hours of Treatment Than Previously Thought
21 nov. 2023 13h41 HE | Catalight
Walnut Creek, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Each year, tens of thousands of parents and caregivers of children with autism spectrum disorder (ASD) face vital decisions: What kind of...